Saturday , April 17 2021

Covid-19 vaccines take a long weekend as the Department of Health expects more J&J hits



The number of vaccinated health workers occurred during the Easter weekend.  (Photo: Alet Pretorius, Gallo Images)

The number of vaccinated health workers occurred during the Easter weekend. (Photo: Alet Pretorius, Gallo Images)

  • The number of vaccinated health workers stagnated at 269,102 from Thursday to Sunday.
  • As of Monday, there were 452 new confirmed cases bringing the total to 1,552,416.
  • Eight deaths were recorded.

The Department of Health did not report any new vaccinations performed on health personnel over the Easter weekend.

According to Health Minister Zweli Mkhize’s spokesman Lwazi Manzi, the department was still waiting for another 200,000 vaccines against Johnson & Johnson.

Manzi said the batch was expected to arrive over the weekend.

The number of vaccinated health workers stabilized at 269,102 from Thursday to Sunday in the department’s daily reports.

No additional number of vaccinated workers was reflected in Monday’s report.

READ “Distributing vaccines is not a rocket science” – Archbishop Makgoba claims the government

Manzi, however, said the department still expected to use 20,000 vaccines this week.

On Monday, the country recorded 452 confirmed cases of Covid-19, bringing the cumulative number to 1,552,416.

The report indicated that 11,091 new tests were performed, bringing the total to 9,979,294.

READ HERE | Business leaders attend “crisis meeting” with President Ramaphosa on vaccine deployment

Eight more deaths were also recorded, bringing the total to 52,995. According to the report, the Eastern Cape, Limpopo, Mpumalanga, Northern Cape and Western Cape did not record any deaths.

Recoveries stood at 1,478,088, accounting for 95 percent, Mkhize said.

READ ALSO | Covid-19 wrapper: global death toll exceeds 3 million, and WHO does not currently support vaccination passports

News24 reported last week that the

The South African Health Regulatory Authority (Sahpra) registered the Johnson & Johnson vaccine with conditions. This meant that the vaccine could now be used commercially.

Sahpra said the vaccine, developed by Janssen Pharmaceutical Companies of J&J, was subject to several conditions, including the need to supply and administer it according to the Department of Health’s Covid-19 vaccination plan.


Did you know that you can comment on this article? Subscribe to News24 and add your voice to the conversation.


Source link